ABMD
ABIOMED, Inc.
Halal Rating :
Last Price
$381.19
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Feb. 2, 2023
ABIOMED, Inc. is a pioneer and global leader in healthcare technology and innovation, specializing in temporary mechanical circulatory support devices. The company's main product line includes the Impella platform of heart pumps, designed to provide minimally invasive cardiac support for patients undergoing high-risk procedures or experiencing cardiogenic shock.
The company was acquired by Johnson & Johnson in December 2022 and is now part of Johnson & Johnson MedTech.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2022 | $265.92m | $207.93m | - | - | 0.00% | 0.00% |
| June 30, 2022 | $277.15m | $211.1m | - | - | 0.00% | 0.00% |
| March 31, 2022 | $269.85m | $205.34m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate ABIOMED, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.